Is semaglutide or tirzepatide stronger for weight loss?

Clinical trial data shows tirzepatide producing greater average weight loss (up to 20.9% in SURMOUNT-1) compared to semaglutide 2.4 mg (14.9% in STEP-1). However, these trials used different populations and designs, and no direct head-to-head study at equivalent maximum weight management doses has been published. Individual responses vary significantly.

Are semaglutide and tirzepatide reconstituted the same way?

Yes, the physical process is identical: dissolve the lyophilized powder in bacteriostatic water by injecting BAC water slowly down the inner wall of the vial, then swirl gently. The key difference is concentration strategy. Tirzepatide doses are much larger (mg range vs. mcg range for semaglutide), so you often need a higher concentration to keep injection volumes manageable.

Can I use the same syringe for both semaglutide and tirzepatide?

Yes. U-100 insulin syringes (28-31 gauge) work for both. However, you may need a larger syringe (0.5 mL or 1 mL vs. 0.3 mL) for tirzepatide at higher doses and lower concentrations, since the draw volume can exceed 0.3 mL.

What is the difference between 1 mg/mL and 5 mg/mL concentration?

The concentration determines how much liquid you draw for a given dose. At 1 mg/mL, a 5 mg tirzepatide dose requires drawing 5 mL, which is far too large for a single subcutaneous injection. At 5 mg/mL, the same dose requires only 1 mL, which is still large. For tirzepatide at high doses, 5 mg/mL is generally preferred, keeping most doses under 0.3 mL per injection.

Do semaglutide and tirzepatide have the same side effects?

Both compounds share GLP-1 class side effects: nausea, vomiting, diarrhea, and constipation, particularly during dose escalation. These are typically transient and diminish as the body adjusts. The slow titration schedule for both compounds exists specifically to minimize these effects.

How do I know when to increase my dose during titration?

Standard protocols advance the dose every 4 weeks if the current dose is tolerated without significant side effects. If gastrointestinal side effects are significant, maintaining the current dose for an additional 4 weeks before increasing is common practice. All dosing decisions should involve a healthcare provider.

Semaglutide vs Tirzepatide: Dosing Comparison

Semaglutide and tirzepatide are both injectable peptides used for weight management and metabolic health. Despite sharing a similar injection process, they differ substantially in receptor activity, dose range, and how you set up your concentration for reconstitution.

Mechanism: Where They Differ

Semaglutide is a selective GLP-1 receptor agonist. It mimics glucagon-like peptide-1, which stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite. Tirzepatide is a dual agonist, targeting both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. The addition of GIP activity is believed to account for tirzepatide's greater average weight loss in clinical trials.

Dose Ranges: A Critical Reconstitution Difference

This is the most practically important difference for reconstitution. Semaglutide is dosed in the hundreds of micrograms range. Tirzepatide is dosed in milligrams, starting 10 times higher. This changes how you choose your BAC water volume and syringe strategy.

Semaglutide starting dose: 0.25 mg (250 mcg) per week
Semaglutide maximum dose: 2.4 mg per week (Wegovy label)
Tirzepatide starting dose: 2.5 mg per week
Tirzepatide maximum dose: 15 mg per week

Concentration Strategy: Side by Side

Because tirzepatide doses are much larger, the concentration you choose has a bigger effect on injection volume. The table below shows common setups for each compound.

Semaglutide Concentrations

2 mg vial + 2 mL BAC water = 1 mg/mL (25 units per 0.25 mg dose)
5 mg vial + 2.5 mL BAC water = 2 mg/mL (12.5 units per 0.25 mg dose)
10 mg vial + 2 mL BAC water = 5 mg/mL (10 units per 0.5 mg dose)

Tirzepatide Concentrations

5 mg vial + 5 mL BAC water = 1 mg/mL (62.5 units per 2.5 mg starting dose)
5 mg vial + 2.5 mL BAC water = 2 mg/mL (31 units per 2.5 mg starting dose)
10 mg vial + 2 mL BAC water = 5 mg/mL (25 units per 2.5 mg starting dose)
15 mg vial + 3 mL BAC water = 5 mg/mL (37.5 units per 3.75 mg dose)

For semaglutide, 1 mg/mL is the most practical general concentration. For tirzepatide at higher doses (7.5 mg+), 5 mg/mL keeps injection volume under 0.3 mL per shot. Use PeptiTools to verify units for your exact setup.

Titration Schedules Compared

Both compounds require a slow titration period to minimize gastrointestinal side effects. The schedules differ in duration and step size, reflecting the different dose ranges.

Semaglutide Titration

Weeks 1-4: 0.25 mg/week
Weeks 5-8: 0.5 mg/week
Weeks 9-12: 1 mg/week
Weeks 13-16: 1.7 mg/week (if tolerating well)
Week 17+: 2.4 mg/week (maintenance)

Tirzepatide Titration

Weeks 1-4: 2.5 mg/week
Weeks 5-8: 5 mg/week
Weeks 9-12: 7.5 mg/week
Weeks 13-16: 10 mg/week
Weeks 17-20: 12.5 mg/week
Week 21+: 15 mg/week (maximum)

Clinical Weight Loss Data

Both compounds have large, high-quality Phase 3 clinical trials for weight management. The STEP-1 trial for semaglutide 2.4 mg showed a mean weight loss of approximately 14.9% of body weight over 68 weeks in adults with obesity. The SURMOUNT-1 trial for tirzepatide showed mean weight loss of 20.9% (15 mg dose) over 72 weeks.

The SURPASS-2 trial compared tirzepatide directly to semaglutide 1 mg in people with type 2 diabetes. All three tirzepatide doses (5 mg, 10 mg, 15 mg) produced greater reductions in HbA1c and body weight than semaglutide 1 mg, which is a lower dose than the 2.4 mg used in the STEP-1 weight loss trial. A direct head-to-head trial at maximum weight management doses has not yet been published.

Reconstitution Process: What Is the Same

Despite the dose differences, the physical reconstitution process is identical for both compounds. Both are lyophilized powders that dissolve in bacteriostatic water. Both should be stored at 2-8°C after reconstitution, remain stable for up to 28 days refrigerated, and should be discarded if the solution turns cloudy or discolored. The same U-100 insulin syringes work for both.

Which Calculator to Use

PeptiTools has dedicated calculator pages for both compounds, pre-loaded with typical vial sizes and starting doses. For any custom vial size or concentration, use the general calculator.

Semaglutide CalculatorPre-loaded with 2 mg, 5 mg, and 10 mg vial options and 0.25 mg starting dose.

→

Tirzepatide CalculatorPre-loaded with titration schedule from 2.5 mg to 15 mg weekly doses.

→

General Peptide CalculatorEnter any vial size, BAC water volume, and dose for a custom result.

→

Semaglutide Reconstitution GuideFull step-by-step guide with concentration examples and storage tips.

→

Tirzepatide Reconstitution GuideConcentration strategy and titration schedule for tirzepatide.

→